首页> 外文期刊>Investigative ophthalmology & visual science >The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits
【24h】

The effect of triamcinolone acetonide or bevacizumab on the levels of proinflammatory cytokines after retinal laser photocoagulation in pigmented rabbits

机译:醋酸曲安奈德或贝伐单抗对有色家兔视网膜激光光凝后促炎细胞因子水平的影响

获取原文
       

摘要

Purpose : To investigate the changes in inflammatory and angiogenic cytokine levels in aqueous humor and vitreous body after intravitreal injection of bevacizumab (IVB) or triamcinolone (IVTA), as well as sub-Tenon injection of triamcinolone (STTA) after retinal laser photocoagulation in rabbits. Methods : Pigmented rabbits were treated with retinal laser photocoagulation and divided into 4 groups, namely Control (no additional treatment), IVB, IVTA or STTA accordingly. Samples of vitreous and aqueous humor were collected on post-treatment days 0, 1, 7 and 14. The levels of intraocular vascular endothelial growth factor (VEGF), interleukin-6 (IL-6), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemotactic protein-1 (MCP-1) were measured using an immunoassay. Results : The levels of VEGF, IL-6, ICAM-1 and MCP-1 were significantly elevated 1 day after laser treatment (P0.05). IVTA and STTA significantly reduced the increase in the levels of VEGF, IL-6, ICAM-1 and MCP-1, while IVB reduced that of VEGF only in aqueous humor and vitreous body (P0.05, unpaired student t-test). The protein amount in the aqueous humor transiently increased 1 day after laser, and was significantly prevented by IVTA or STTA but not IVB. Conclusions : Data showed that bevacizumab only reduced intraocular VEGF after laser, while triamcinolone suppressed both the expression of VEGF and proinflammatory cytokines. We propose that these cytokine profiles may play an important role in the pathogenesis of inflammation after photocoagulation and the underlying mechanism of treatment with anti-VEGF drug and corticosteroids. This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.
机译:目的:研究玻璃体腔注射贝伐单抗(IVB)或曲安奈德(IVTA)以及视网膜下激光光凝后特隆(Tenon)注射曲安奈德(STTA)后房水和玻璃体中炎症和血管生成细胞因子水平的变化。 。方法:对色素沉着的兔进行视网膜激光光凝治疗,分为对照组(不加治疗),IVB,IVTA或STTA 4组。在治疗后第0、1、7和14天收集玻璃体和房水样品。眼内血管内皮生长因子(VEGF),白介素6(IL-6),细胞间黏附分子1(ICAM- 1)和单核细胞趋化蛋白-1(MCP-1)使用免疫测定法测量。结果:激光治疗1天后,VEGF,IL-6,ICAM-1和MCP-1水平显着升高(P <0.05)。 IVTA和STTA显着降低了VEGF,IL-6,ICAM-1和MCP-1的水平升高,而IVB仅在房水和玻璃体中降低了VEGF的水平(P <0.05,未配对学生t检验)。激光后1天,房水中的蛋白质量瞬时增加,被IVTA或STTA显着阻止,但没有被IVB阻止。结论:数据显示贝伐单抗仅能降低激光后眼内VEGF的含量,而曲安西龙同时抑制VEGF的表达和促炎细胞因子。我们建议这些细胞因子概况可能在光凝后炎症的发病机理中以及在抗VEGF药物和皮质类固醇治疗的潜在机制中起重要作用。这是提交给2016年5月1-5日在华盛顿州西雅图市举行的2016 ARVO年会的摘要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号